MedTech Innovator named Vektor Medical its 2026 mid-stage grand prize winner on November 5 at the MedTech Strategist Innovation Summit in San Diego. The award carries $200,000. Vektor's vMap software identifies likely arrhythmia sources from a standard 12-lead ECG and uses them to guide ablation.

Lenneuro won the $25,000 Execution Award for SnapCath, a snap-on lid that covers and anchors catheter tubing at the insertion site. The Colville, Washington company says the device is not cleared by FDA and is not yet for sale. The other four mid-stage finalists, Axoft, Portal Instruments, Tau Medical and VIS, each took $25,000.

Cerevia Neurosciences, GenAssist, Lucentia and Optheras filled out the Execution Award shortlist. Four of the ten finalists sit outside the United States.

Prize money at this size does not move a cap table. The screen is the asset. MedTech Innovator ran 65 companies through its 2026 cohort, and the strategics sitting on its selection panels are the same ones a mid-stage device company is already trying to reach.